These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5182290)

  • 1. Tolerance to ethionamid and PAS in original treatment of tuberculous patients.
    Verbist L; Prignot J; Cosemans J; Gyselen A
    Scand J Respir Dis; 1966; 47(4):225-35. PubMed ID: 5182290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Frequency of side-effects of tuberulostatics and its relation to the applied combination].
    Bethge W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early results of a modified treatment of 100 cases of newly detected tuberculosis with standard drugs with the substitution of PAS for ethionamide].
    Piekarniak K; Danilczuk R; Martyniak K; Wyczółkowski M
    Gruzlica; 1973 Aug; 41(8):837-43. PubMed ID: 4755391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients].
    Benda R; Le Guillou F
    Sem Ther; 1965 Jan; 41(1):19-21. PubMed ID: 5879027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trevintix in the treatment of tuberculous patients (tolerance evaluation)].
    Pregowski W; Zagórecka A
    Gruzlica; 1968; 37(1):39-42. PubMed ID: 5720036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 9. The need for new antituberculous drugs.
    Dahlström G
    Scand J Respir Dis Suppl; 1969; 69():11-3. PubMed ID: 4906370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
    Tubercle; 1968 Jun; 49(2):125-35. PubMed ID: 5243159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the adverse effects of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Rózewska M
    Gruzlica; 1969 Dec; 37(12):1103-6. PubMed ID: 5368636
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of allergy to antituberculous drugs (PAS, SM and INH) in tuberculous patients.
    Brown H; Jennings TS; Coleman EO; Bulubash V
    Med Ann Dist Columbia; 1966 Dec; 35(12):652-7 passim. PubMed ID: 5231829
    [No Abstract]   [Full Text] [Related]  

  • 14. Madras Study of intermittent oral chemotherapy.
    Tripathy SP
    Bull Int Union Tuberc; 1972 Feb; 47():30-6. PubMed ID: 5077117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early results of intermittent and continuous modified treatment with standard drugs and limited dosage of PAS in previously untreated pulmonary tuberculosis. Preliminary report].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M
    Gruzlica; 1970; 38(7):705-18. PubMed ID: 5453680
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 18. [The algodystrophies caused by antituberculous chemotherapy. Study of 24 cases].
    Renier JC; Oury M; Bregeon C; Tuchais E
    Rev Rhum Mal Osteoartic; 1969 Nov; 36(11):605-7. PubMed ID: 5367163
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of various compounds of PAS].
    Potworowska M; Wareska W; Lachowicz E; Pecyna-Sielewicz J; Ambroziak-Miller M
    Gruzlica; 1969 Jul; 37(7):673-80. PubMed ID: 4900504
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to cycloserine.
    Riska N
    Scand J Respir Dis Suppl; 1970; 71():209-16. PubMed ID: 5271988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.